Jubilant gets USFDA nod for generic levofloxacin tablets
The company has received approval from the US Food and Drug Administration (USFDA) to market generic version of Levaquin tablets in strengths of 250 mg and 500 mg in the American market, the firm said in a statement.
Jun 23, 2015, 15:39 PM IST